Chemoinformaics analysis of (+)-8-Acetoxy-Carvone
Molecular Weight | 208.257 | nRot | 2 |
Heavy Atom Molecular Weight | 192.129 | nRig | 9 |
Exact Molecular Weight | 208.11 | nRing | 1 |
Solubility: LogS | -2.247 | nHRing | 0 |
Solubility: LogP | 1.66 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 33.1147 |
nHD | 0 | BPOL | 19.5233 |
QED | 0.515 |
Synth | 4.397 |
Natural Product Likeliness | 1.845 |
NR-PPAR-gamma | 0.014 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.004 |
HIA | 0.005 |
CACO-2 | -4.555 |
MDCK | 0.0000322 |
BBB | 0.982 |
PPB | 0.380128 |
VDSS | 0.711 |
FU | 0.731572 |
CYP1A2-inh | 0.018 |
CYP1A2-sub | 0.517 |
CYP2c19-inh | 0.028 |
CYP2c19-sub | 0.772 |
CYP2c9-inh | 0.008 |
CYP2c9-sub | 0.078 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.132 |
CYP3a4-inh | 0.129 |
CYP3a4-sub | 0.4 |
CL | 5.354 |
T12 | 0.654 |
hERG | 0.006 |
Ames | 0.321 |
ROA | 0.719 |
SkinSen | 0.245 |
Carcinogencity | 0.898 |
EI | 0.132 |
Respiratory | 0.96 |
NR-Aromatase | 0.032 |
Antiviral | No |
Prediction | 0.637204 |